TransMedics Posts US$203.01M Revenue, Raises Full-Year Outlook
TransMedics reported third-quarter 2026 revenue of US$203.01 million and net income of US$17.07 million, then raised full-year guidance amid declining industry donor volumes.
Topic
Revenue Guidance
Topic
Revenue Guidance
Datadog Shares Slide 10% After In-Line Forecast Disappoints
Datadog shares fell over 10% after its Q4 revenue forecast of $1.19B-$1.2B merely matched expectations, extending a five-day, 21%…
Pfizer raises full-year outlook, names Cecile Guegan as CFO
Pfizer lifted full-year revenue guidance to $62 billion–$64 billion, beat third-quarter estimates and named finance veteran Cecil…
UPS Raises Full-Year Outlook to $92.6 Billion After Q3 Beat
UPS raised full-year revenue guidance to $92.6 billion after Q3 beats: $1.69 adjusted EPS vs $1.63 expected, $22.9 billion revenu…
Super Micro Hikes Quarterly Revenue Outlook to $19.5 Billion, Stock Soars 16%
Super Micro raised September-quarter revenue guidance to $18.5-$19.5 billion, up from $14.5-$15.5 billion, and lifted gross margi…
Fastly Targets Up to $1.3 Billion Revenue by 2029 on AI Traffic
Fastly targets $1.1B–$1.3B revenue by 2029, betting on security growth and AI traffic that it says is expanding 6.5 times faster…